Gland Pharma Q3 Results
- BSE: 543245
- NSE: GLAND
- ISIN: INE068V01023
- Sector: Biotechnology & Drugs
BSE
2,475.00
14.65 (0.60%)
14.65 (0.60%)Volume20.00 K
Updated: Tue 14 Jul, 2026 | 15:29:59
NSE
2,488.3027.10 (1.10%)
27.10 (1.10%)Volume4.92 L
Updated: Tue 14 Jul, 2026 | 15:41:57
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Gland Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,392.48 | 1,202.60 | 8.85% | 1,294.11 | 24.28% |
| Depreciation/ Amortization | 107.65 | 93.83 | 1.26% | 105.34 | 11.75% |
| Operating Income | 302.89 | 203.23 | 45.92% | 251.05 | 14.89% |
| Net Income | 261.48 | 163.53 | 42.35% | 191.86 | 27.74% |
| Other Operating Expenses Total | 205.63 | 158.13 | 11.77% | 180.16 | 25.48% |
| Net Income Before Taxes | 362.13 | 256.78 | 27.55% | 283.16 | 20.99% |
| Total Revenue | 1,695.36 | 1,405.83 | 14.02% | 1,545.16 | 22.49% |
| Selling/ General/ Admin Expenses Total | 424.20 | 375.19 | 10.17% | 409.37 | 6.71% |
| Diluted Normalized EPS | 16.94 | 9.93 | 51.90% | 11.65 | 36.37% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.